Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Sandler

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The New England Journal of Medicine|August 2, 1984
Long-term follow-up of an untreated patient with probable prolactinomaJ Cassar, R T Yeung, S C Gonticas, et al.
Clinical Science (London, England : 1979)|April 1, 1982
The effect of renal function on changes in circulating concentrations of 1,25-dihydroxycholecalciferol after an oral doseS E Papapoulos, T L Clemens, L M Sandler, et al.
Clinical Endocrinology|January 1, 1987
Effective long-term treatment of acromegaly with a long-acting somatostatin analogue (SMS 201-995)L M Sandler, J M Burrin, G Williams, et al.
The Quarterly Journal of Medicine|January 1, 1984
Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3L M Sandler, C G Winearls, L J Fraher, et al.
The Quarterly Journal of Medicine|January 1, 1982
Long-term effects of 1,25-dihydroxy vitamin D3 and 24,25-dihydroxy vitamin D3 in renal osteodystrophyN Muirhead, S Adami, L M Sandler, et al.
Lancet (London, England)|March 24, 1979
1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosisS E Papapoulos, T L Clemens, L J Fraher, et al.
British Medical Journal (Clinical Research Ed.)|January 26, 1985
Long term treatment of acromegaly with a long acting analogue of somatostatinL J Ch'ng, L M Sandler, M E Kraenzlin, et al.
The Quarterly Journal of Medicine|January 1, 1983
Familial benign hypercalcaemia. Study of a large familyF H Menko, O L Bijvoet, J L Fronen, et al.
Clinical Endocrinology|May 1, 1982
Control of secretion of parathyroid hormone in secondary hyperparathyroidismS Adami, N Muirhead, R M Manning, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The New England Journal of Medicine|August 2, 1984
Long-term follow-up of an untreated patient with probable prolactinomaJ Cassar, R T Yeung, S C Gonticas, et al.
Clinical Science (London, England : 1979)|April 1, 1982
The effect of renal function on changes in circulating concentrations of 1,25-dihydroxycholecalciferol after an oral doseS E Papapoulos, T L Clemens, L M Sandler, et al.
Clinical Endocrinology|January 1, 1987
Effective long-term treatment of acromegaly with a long-acting somatostatin analogue (SMS 201-995)L M Sandler, J M Burrin, G Williams, et al.
The Quarterly Journal of Medicine|January 1, 1984
Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3L M Sandler, C G Winearls, L J Fraher, et al.
The Quarterly Journal of Medicine|January 1, 1982
Long-term effects of 1,25-dihydroxy vitamin D3 and 24,25-dihydroxy vitamin D3 in renal osteodystrophyN Muirhead, S Adami, L M Sandler, et al.
Lancet (London, England)|March 24, 1979
1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosisS E Papapoulos, T L Clemens, L J Fraher, et al.
British Medical Journal (Clinical Research Ed.)|January 26, 1985
Long term treatment of acromegaly with a long acting analogue of somatostatinL J Ch'ng, L M Sandler, M E Kraenzlin, et al.
The Quarterly Journal of Medicine|January 1, 1983
Familial benign hypercalcaemia. Study of a large familyF H Menko, O L Bijvoet, J L Fronen, et al.
Clinical Endocrinology|May 1, 1982
Control of secretion of parathyroid hormone in secondary hyperparathyroidismS Adami, N Muirhead, R M Manning, et al.
Pageof 2